Diagnostic Imaging Markers Market: FMI Explores Advanced Technology and Solutions for Next-Generation Products

The use of electromagnetic radiation and related technologies to obtain images of internal structures of the body for accurate diagnosis is known as medical or diagnostic imaging. A diagnostic imaging marker is a biomarker or a biologic feature that is detectable in an image. This image is relevant to the diagnosis of a patient for a certain disease. Diagnostic imaging includes certain radiation technique; X-Ray imaging, endoscopy, magnetic resonance imaging, computed tomography scan, ultrasound etc. The diagnostic imaging markers are either placed in or around the part of the body that needs to be screened. These markers help in target localization of the tumor or the diseased organ. Digital imaging markers aid in knowing the exact position of the tumor, further depicting the severity, shape and size of the diseased organ/ tumor. Diagnostic imaging markers are highly used for cancer diagnosis. For instance, for lung cancer, these diagnostic imaging markers can be used for the assessment the calcification, cavitation, spiculation, rate of growth, location within the lung, and rate of metabolism of the tumor.

Diagnostic Imaging Markers Market: Drivers and Restraints-

Increasing incidence of various forms of cancer, like lung, skin, abdomen, kidney, prostate, breast, etc., and other chronic diseases that require diagnostic imaging for better diagnosis of the disease is expected to be a major factor driving the diagnostic imaging markers market during the forecast period. Growing FDA approvals for these markers are contributing to better and novel technologies for better diagnosis of these diseases. This is also expected to boost the diagnostic imaging markers market. Technological advancements in the imaging modalities and growing preference for minimally invasive procedures for diagnosis might also drive the market growth for diagnostic imaging markers during the forecast period. However, extremely high costs associated with diagnostic imaging systems, unfavorable healthcare reforms and stand-alone systems limitations might hinder the market growth for diagnostic imaging markers market during the forecast period.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7960

Diagnostic Imaging Markers Market: Segmentation

On the basis of Application, Diagnostic Imaging Markers Market can be segmented as: X-ray, Bone Scan, DEXA Scanning, Mammography, Ultrasound, Magnetic Resonance Imaging, Positron Emission Tomography Scan, Computed Tomography Scan, Other; On the basis of end users, Diagnostic Imaging Markers Market can be segmented as: Hospitals, Diagnostic Centers, Radiotherapy Centers, Clinics, Others; On the basis of geography, Diagnostic Imaging Markers Market can be segmented as: North- America Eastern Europe, Western Europe, Asia-Pacific excluding China & Japan, China, Japan, Middle East and  africa, Latin America.

Diagnostic Imaging Markers Market: Overview

Global Diagnostic Imaging Markers market has witnessed growth due to expanding demand for diagnostic services. According to the World Health Organization, certain surgical interventions can be avoided if diagnostic imaging is available, like ultrasound and X-ray procedures. There is a consistent increment in skin related disorders leading to cancer growths. Increase in oncology diseases and related ailments is boosting a high demand for Diagnostic Imaging Markers. Diagnostic Imaging Markers for dermatology services is also being practiced rigorously. Growing incidences of skin disorders and related ailments is also responsible for boosting the market growth for diagnostic imaging markers. Government support and funding is also resulting in increase in number of cancer and other related diagnostic centers.

Diagnostic Imaging Markers Market: Region-wise Outlook

Geography wise, Diagnostic Imaging Markers market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s Diagnostic Imaging Markers market is expanding because of increase in FDA approved markers and high availability of diagnostic systems in diagnostic centers. The market is expected to remain dominant during the period of forecast due to increasing government funding and increase in healthcare expenditure. North America’s Diagnostic Imaging Markers market is expected to grow the fastest due to high number of cancer cases and growing geriatric population requiring diagnostic treatment and services. Asia-Pacific Diagnostic Imaging Markers market is anticipated to grow at a decent rate due to growing awareness on Diagnostic Imaging Markers, growing medical tourism and development of healthcare facilities in the region.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7960

Diagnostic Imaging Markers Market: Key Market Participants

Some of the market participants in the Global Diagnostic Imaging Markers market identified across the value chain include: PDC Healthcare, IBA, Hologic Inc, Magic X-Ray Markers, Innovative Oncology Solutions, Boston Scientific, IBA, Best Medical International, Inc., IZI Medical Products, Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S and Stellar Medical.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office, 616 Corporate Way, Suite 2-9018,, Valley Cottage, NY 10989,, United States, T: +1-347-9
616 Corporate Way, Suite 2-9018,

This release was published on openPR.